Mortality and Parkinson disease: A community based study.
OBJECTIVE
To compare the mortality of a community-based cohort of patients with carefully diagnosed Parkinson disease (PD) with the mortality in an age-matched population from the same study area and to investigate the possible influence of clinical features and diagnostic accuracy on survival in PD.


METHODS
A total of 245 patients with PD were identified and included in the study. Patients were classified into groups of clinical definite, probable, and possible PD. The study period was 8 years. A total of 142 patients died. The mortality rates for the Norwegian population, which were available in 1-year intervals for all birth cohorts and both sexes during the study period, were used as controls.


RESULTS
The standardized mortality ratio (SMR) for the total patient group was 1.52. The mortality rate was increased for both sexes (male SMR = 1.54, female SMR = 1.49) and in all age groups at disease onset (<60 years SMR = 1.92, 60 to 70 years SMR = 1.50, >70 years SMR = 1.41). The survival of patients with clinical definite PD was only modestly reduced (SMR = 1.35), whereas the SMR for possible PD was as high as 1.99.


CONCLUSIONS
Our study gives evidence for increased mortality in PD despite modern treatment. The increase is not extensive in patients with a high probability for idiopathic PD.
Herlofson
Karen
K
Departments of Neurology (Drs. Herlofson and Larsen) and Psychiatry (Dr. Arsland), Central Hospital of Rogaland, Stavanger.
Lie
Stein Atle
SA
Arsland
Dag
D
Larsen
Jan P
JP
D000368:Aged; D015331:Cohort Studies; D003710:Demography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009026:Mortality / Q000639:trends; D009664:Norway / Q000453:epidemiology; D010300:Parkinson Disease / Q000401:mortality*; D015995:Prevalence; D015996:Survival Rate / Q000639:trends